John Brendan Doyle

CGTX

John Brendan Doyle serves as officer: Chief Financial Officer at Cognition Therapeutics, Inc. (CGTX). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

1 trades

$11.3K

Total Sells

7 trades

$72.1K

Net Position

Net Seller

$60.8K

Companies Traded

CGTX

Active Period

May 2024 – Apr 2026

8 total trades

Most Recent

Buy CGTX

Apr 20, 2026 · $11.3K

John Brendan Doyle's Insider Trading at Cognition Therapeutics, Inc. (CGTX)

Buys

1 · $11.3K

Sells

7 · $72.1K

Total Shares Bought

10,000

Total Shares Sold

67,315

CGTX Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Apr 20, 2026	Buy	10,000	$1.13	$11.3K	627,509
Feb 15, 2026	Sell	1,560	$1.12	$1.7K	0
Feb 3, 2026	Sell	26,921	$1.03	$27.7K	0
Dec 18, 2025	Sell	9,360	$1.50	$14.0K	0
Jul 29, 2025	Sell	9,360	$0.67	$6.3K	0
May 1, 2025	Sell	9,692	$0.45	$4.3K	0
Feb 15, 2025	Sell	1,723	$0.59	$1.0K	0
May 1, 2024	Sell	8,699	$1.95	$17.0K	0

Related Insiders

Anthony Caggiano

officer: Chief Medical Officer

CGTXBuy · Apr 20, 2026

Lisa Ricciardi

director, officer: CEO & President

CGTXBuy · Apr 20, 2026

Explore More Insider Trading Data

CGTX Insider Trading Activity

View all insider trades at Cognition Therapeutics, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity